Navigation Links
AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
Date:6/16/2009

    GAI-122, an investigational injectable nano-emulsion formulated with
    AlphaRx's proprietary drug delivery technology, provides significant
    neuroprotection in animal behavioral models. Gaia BioPharma plans to
    initiate a clinical development program to further study GAI-122 for an
    acute and as yet, unmet neurological indication.

MARKHAM, ON, June 16 /PRNewswire-FirstCall/ - AlphaRx Inc. (OTCBB: ALRX) and Gaia BioPharma Limited, a privately held, early stage biopharmaceutical company focused on hospital-based injectable therapeutics, are pleased to provide a progress report on GAI-122.

GAI-122 offers significant and direct neuroprotection in both in vitro and in vivo ischemic conditions. Experimental evidence suggests that the neuroprotective action of GAI-122 is related to its' active inhibition of apoptosis or cell death. GAI-122 shows potential as a major treatment innovation in the management of ischemic neurological disorders such as stroke and traumatic brain injury.

The proposed initial indication for GAI-122 is an acute neurological disorder affecting millions of patients undergoing cardiac and hip replacement surgery. It is estimated that the market potential for this unmet indication exceeds US$2 billion a year.

GAI-122 is in the final stage of formulation optimization, which is expected to be completed by the end of summer 2009, proceeding to clinical trial materials manufacturing thereafter. GAI-122 is protected by 4 US patent applications.

In October 2008, AlphaRx licensed GAI-122 to Gaia BioPharma. Under the terms of the amended agreement, AlphaRx is eligible to receive milestone payments of up to $50 million for the successful development and commercialization of GAI-122, as well as royalties on worldwide sales. In addition, Gaia BioPharma has assumed all development costs.

About AlphaRx Inc.

AlphaRx is a specialty pharmaceutical compa
'/>"/>

SOURCE AlphaRx Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AlphaRx Signs Cooperative Research and Development Agreement with US Army
2. AlphaRx Provides Corporate and Development Update
3. AlphaRxs Indaflex(TM) Continues its Clinical Development
4. AlphaRx CEO Accumulates More Company Shares
5. AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares
6. AlphaRx Announces Debt Conversion
7. AlphaRx To Present at 47th Annual ICAAC
8. PDL BioPharma Announces Record Date for October 1 Dividend Payment
9. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
10. SAFE-BioPharma Webinar Featuring ARX's Digital Signatures Combined with Microsoft SharePoint for Bio-Pharma industry
11. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... attained the distinguished Magnet hospital designation by the ... Considered the gold standard for nursing excellence, the ... professionalism. It is the top international credential for ... Newport Hospital was based on the hospital,s continued ... , "It is a privilege for us to ...
(Date:8/22/2014)... may do little to help young people with drinking ... studies that included nearly 18,000 people 25 and younger, ... problems. Participants in 49 studies attended a single one-on-one ... studies attended group sessions or a mix of group ... interviewing was used in the studies. This technique was ...
(Date:8/22/2014)... previous few years, several breakthrough treatments have become ... who may benefit from these treatments can be ... their cancer. For example, patients whose lung cancer ... derive significant benefit from the drug crizotinib, which ... now attempting to replicate this success by matching ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 ItsHot.com, a ... now offering 60-80% off on its range of beautiful ... the purchase of Gold Hearts 14K White Rose Gold ... a discount of 77%. Previously priced at $3,715.00, ... $859.00. The item code of this mesmerizing pendant embedded ...
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 “Dr. Luciana ... Luciana Lagana , aka Dr. Luciana, is finding it challenging ... budget and while taking care of hundreds of students, so ... trailer for the show is completed, and she recently entered ... fun projects including those of her husband, actor/screenwriter Gregory ...
Breaking Medicine News(10 mins):Health News:Newport Hospital receives nursing's highest credential for third time with Magnet recognition 2Health News:Counseling Does Little to Deter Youth Drinking, Review Finds 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 2Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 3Health News:Online screening for rare lung cancer subtypes opens door to new kind of clinical trial 4Health News:ItsHot.com Now Offers 60-80% Discount on its Striking Collection of Diamond Heart Pendants 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4
... of new guidelines for cardiac specialists has been developed ... mechanical heart-pumping device. "The new guidelines will likely ... device, and how early in the process a physician ... Jeffrey A. Morgan, M.D., associate director of Mechanical Circulatory ...
... HealthDay Reporter , FRIDAY, April 15 (HealthDay News) -- ... showing early signs of dementia, researchers from the University of ... diagnose which type of dementia a patient has and start ... dementia patients tended to have difficulty identifying the form of ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, ... chronic urinary tract infections, but now a new treatment ... a preliminary trial indicates. Urinary tract infections frequently ... all women. The depletion of vaginal Lactobacillus crispatus ...
... , FRIDAY, April 15 (HealthDay News) -- Teens who start ... traffic crashes, a new study finds. But starting the ... and reduce impulsiveness, another study finds. In 2008, the ... Beach, Va., was about 41 percent higher than for the ...
... Steven Reinberg HealthDay Reporter , THURSDAY, April 14 ... increase in hard times and decrease during years of prosperity, ... of people jumping from windows after the stock market crash ... the U.S. Centers for Disease Control and Prevention. "The ...
... A study in the April 15 issue of the Journal ... teen drivers who start school earlier in the morning. Results ... 18-year-olds was about 41 percent higher in Virginia Beach, Va., where ... adjacent Chesapeake, Va., where classes started at 8:40 - 8:45 a.m. ...
Cached Medicine News:Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 2Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 3Health News:New Treatment for Urinary Tract Infections Called Promising 2Health News:New Treatment for Urinary Tract Infections Called Promising 3Health News:Early School Start Tied to More Teen Crashes: Study 2Health News:Suicide Rates Rise and Fall With the Economy: CDC 2Health News:Suicide Rates Rise and Fall With the Economy: CDC 3Health News:Crash rates may be higher for teen drivers who start school earlier in the morning 2Health News:Crash rates may be higher for teen drivers who start school earlier in the morning 3
(Date:8/22/2014)... ITHACA, N.Y. , Aug. 22, 2014 /PRNewswire/ ... computed tomography (CT) imaging facility, is using the ... 4D and even 5D imaging to researchers and ... just launched, asks "What would YOU do if ... the possibility to researchers and explorers everywhere, from ...
(Date:8/22/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... of common stock and warrants at a price of ... prior to deducting underwriting discounts and commissions and offering ... are immediately separable and will be issued separately.  The ... on The NASDAQ Stock Market under the ticker symbol ...
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
Breaking Medicine Technology:Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2
Universal vacuum pump (capacity 34 L/min, 8 mbar vacuum abs.)...
... Combines BchiVac V-500 with Vacuum Controller V-800 ... switching mechanism turns V-500 on and off as needed ... Model V-500 is a powerful PTFE membrane ... Applications Ideally suited for use with up ...
... is a new addition to the powerful PTFE ... performance pump can achieve an ultimate vacuum of ... L/min. Applications For use with ... Distillation applications from lab size up to ...
... membrane vacuum pump designed to handle most vacuum ... use with up to two rotary evaporators ... ovens, concentrators, gel dryers, and filtration apparatuses ... to chemicals and heat load Corrosion-resistant ...
Medicine Products: